U.S. and Europe Autoinjectors Market
- 2026 年市場規模
- USD 4,421.7 Mn
- 2033 年預估規模
- USD 12,706.6 Mn
- 年複合成長率 CAGR
- 16.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
U.S. and Europe Autoinjectors Market, By Type (Disposable and Reusable), By Molecule Type (Biologics, Hormones, Small Molecules, and Others), By Indication (Anaphylaxis, Diabetes, Autoimmune Diseases, Multiple Sclerosis, Migraine, Hormonal Disorders, and Others), By End User (Hospitals, Home Care Settings, Ambulatory Surgical Centers, and Others)
報告摘要
The U.S. and Europe autoinjectors market is estimated to be valued at USD 4,421.7 Mn in 2026 and is expected to reach USD 12,706.6 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 16.3% from 2026 to 2033. The market for autoinjectors in the U.S. and Europe constitutes a vital market segment in the global medical devices industry. This market continues to grow due to the increase in the number of people suffering from conditions requiring self-administration of medications. The autoinjector market involves various drugs for treating chronic diseases like diabetes, rheumatoid arthritis, multiple sclerosis, and anaphylaxis among others. An autoinjector refers to advanced technology used in delivering doses through an automatic system without necessarily requiring much intervention.
This device makes it possible to deliver accurate doses with reduced errors. The device can be either disposable or reusable and is becoming a popular mode of administration due to continued technological advancements aimed at ensuring easy handling, high efficiency, and safety. In the U.S. and Europe, the increasing demand for autoinjectors results from the aging population, increased inclination towards treatment at home and growing knowledge of healthcare practices.
Market Dynamics
The U.S. and Europe autoinjector market is fueled by the rise in the prevalence of chronic conditions such as diabetes, autoimmune disorders, and serious allergies, which require constant doses. The presence of more aged people in both regions is also among the key drivers, as autoinjectors ensure ease in delivering medications without requiring any healthcare professional. Moreover, advancements in technology, which have led to the development of innovative devices, and the rise in home-based treatments are among the other key drivers.
However, there are various barriers to be addressed, including costly developmental and manufacturing expenses, complex approvals process, and challenges pertaining to the longevity of the device and patient training. Nevertheless, considerable opportunities for speedy development remain open because of the growing adoption of biosimilars, greater funding for healthcare technology research and development, and heightened need for intuitive designs targeting children and elderly patients. Additionally, the advancements in artificial intelligence-assisted dosage and therapy techniques, as well as sustainable material for manufacturing the device, will play an integral part in the evolution of the industry.
Key Features of the Study
• This report provides in-depth analysis of the U.S. and Europe autoinjectors market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the U.S. and Europe autoinjectors market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include SHL Medical AG, Ypsomed AG, BD, West Pharmaceutical Services, Inc., Gerresheimer AG, Owen Mumford Ltd., Recipharm AB, Phillips-Medisize, Amgen Inc., and Eli Lilly and Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The U.S. and Europe autoinjectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. and Europe autoinjectors market
Market Segmentation
• Type Insights (Revenue, USD Mn, 2021 - 2033)
o Disposable
o Reusable
• Molecule Type Insights (Revenue, USD Mn, 2021 - 2033)
o Biologics
o Hormones
o Small Molecules
o Others
• Indication Insights (Revenue, USD Mn, 2021 - 2033)
o Anaphylaxis
o Diabetes
o Autoimmune Diseases
o Multiple Sclerosis
o Migraine
o Hormonal Disorders
o Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals
o Home Care Settings
o Ambulatory Surgical Centers
o Others
• Key Players Insights
o SHL Medical AG
o Ypsomed AG
o BD
o West Pharmaceutical Services, Inc.
o Gerresheimer AG
o Owen Mumford Ltd.
o Recipharm AB
o Phillips-Medisize
o Amgen Inc.
o Eli Lilly and Company
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
U.S. and Europe Autoinjectors Market, By Type
U.S. and Europe Autoinjectors Market, By Molecule Type
U.S. and Europe Autoinjectors Market, By Indication
U.S. and Europe Autoinjectors Market, By End User
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. U.S. and Europe Autoinjectors Market, By Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Disposable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Reusable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. U.S. and Europe Autoinjectors Market, By Molecule Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Biologics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Hormones
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Small Molecules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. U.S. and Europe Autoinjectors Market, By Indication, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Anaphylaxis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Diabetes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Autoimmune Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Multiple Sclerosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Migraine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Hormonal Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. U.S. and Europe Autoinjectors Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Home Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Competitive Landscape
o SHL Medical AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Ypsomed AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o BD
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o West Pharmaceutical Services, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Gerresheimer AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Owen Mumford Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Recipharm AB
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Phillips-Medisize
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Amgen Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Eli Lilly and Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
10. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Autoinjectors Market’– U.S. and Europe forecast to 2033
提及公司
同分類最新報告（醫療器材）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們